Where does Encoded Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Encoded Therapeutics, Inc. ranks #40,022 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Encoded Therapeutics, Inc. hold?

Encoded Therapeutics, Inc. holds 6 US utility patents granted between 2019 and 2025, spanning 5 technology areas.

What is Encoded Therapeutics, Inc.'s Innovation Score?

Encoded Therapeutics, Inc. has an Innovation Score of 34.1 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Encoded Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Encoded Therapeutics, Inc.'s recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Encoded Therapeutics, Inc.'s patents?

Encoded Therapeutics, Inc.'s patents average 25.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Encoded Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Encoded Therapeutics, Inc.

Q: What technology areas does Encoded Therapeutics, Inc. focus on?

Encoded Therapeutics, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 6 patents. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Encoded ranks #40,022 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#40,022
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (34.1/100): 25.7
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R40022 · US Corporation #40,022 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #40,022/49,997
PHOTO-FINISH Empyrean Medical…
CPC-NARROW C12N · 5 areas
INNOV-THIN 34.1/100
CLAIMS-DENSE 25.7 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Empyrean Medical Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Voltronic Power… · near

34
Axure Software… · near

34
Encoded Therapeutics · this assignee

34
Industrial Revolution · near

34
Kathrein SE · near

34
3D Lighting… · lowest

7

What this shows Encoded's Innovation Score is 34.1/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Encoded's grants concentrate

Encoded Therapeutics, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2019 (3 grants) versus a trough of 2 in 2024. By volume, Encoded sits between Empyrean Medical Systems, Inc. and Endur ID, Inc..

Encoded's three-year grant acceleration

Encoded Therapeutics, Inc. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Empyrean Medical…

6
En RX Chemical

6
En-fab

6
Enclear Therapies

6
Endliss Technology

6
Endo Operations

6
Endobar Solutions

6
Endur ID

6
Encoded Therapeut… ◀

6

What this shows Encoded holds 6 patents at rank #40,073, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Encoded

By rank, the assignees closest to #40,073 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Encoded's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Encoded, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Axure Software Solutions, Inc. 34 Industrial Revolution, Inc. 34 Voltronic Power Technology Corp. 34 Kathrein SE 34

Encoded's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Encoded Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	3	50.0%
2024	2	33.3%
2025partial year	1	16.7%

Which technologies does Encoded Therapeutics, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07K - Peptides 5

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#40,022

of 49,997 tracked assignees

Innovation Score

34.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Encoded Therapeutics, Inc.'s patent record in context - here's where to go next.

Encoded Therapeutics, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #40,022 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Encoded Therapeutics, Inc. against Empyrean Medical Systems, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.